Highlights Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
8.32 ^HKD	-1.42%		-2.00%	-58.11%

06-28	Genscript Biotech Units Receive Milestone Payment of $30 Million	MT
06-23	Genscript Biotech Corporation Announces Board Resignations and Changes in Composition of Board Committees	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Genscript Biotech Units Receive Milestone Payment of $30 Million	06-28	MT
GenScript Biotech Corporation Launches FLASH Gene Service: The Most Affordable Gene Synthesis Solution on the Market	06-18	CI
Genscript Biotech CEOs to Receive Shares Under Restricted Share Scheme	06-13	MT
Hong Kong Stocks Rebound Following More than Expected Growth in China’s Manufacturing Sector	06-03	MT
Legend Expects to Log Profit in 2026	05-15	MT
Legend Biotech's Loss Narrows in Q1 as Revenue Surges	05-14	MT
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications	05-13	CI
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	04-23	CI
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug	04-17	MT
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates	03-10	MT
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-10	CI
GenScript Biotech Corporation Expands Collaboration with Roche	03-05	CI
Genscript Biotech Unit Secures US FDA Nod for Carvykti Label Update	12-21	MT
Genscript Biotech's Controlling Shareholder Sells 0.4% Stake to Hillhouse Unit	12-20	MT
Genscript Subsidiary Legend Biotech Grants Novartis License to Develop Anti-Cancer Drug	11-13	MT
GenScript Biotech Corporation Expands its IVT mRNA Synthesis Portfolio with Addition of Customized Circular RNA and Lipid Nanoparticles Formulation Services	23-09-18	CI
Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-20	CI
Genscript Biotech's Q2 Attributable Loss Widens; Shares Fall 3%	23-08-16	MT
GenScript Biotech Corporation Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs	23-08-08	CI
GenScript Biotech's Non-Cell Therapy Business Revenues Seen to Increase in First Half; Shares Drop 7%	23-07-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Highlights

Filters